We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Mycetoma is a chronic, subcutaneous infection that causes local tissue destruction, leading to deformity, disability, and social stigma. Safe and effective treatments for mycetoma are urgently needed; ...

Granules India advanced 1.95% to Rs 519 after the company said that its board has approved to acquire 100% stake in Senn Chemicals AG, a Switzerland based company, for a total consideration of Rs ...

Granules India has acquired Swiss CDMO company Senn Chemicals AG for Rs 192 crore, expanding its peptide therapeutics market presence. The move enhances Granules' CDMO capabilities, leveraging Senn's ...

In a bid to break into the CDMO business at one of its most lucrative angles, India's Granules is snapping up Swiss contract manufacturer Senn Chemicals. The deal, once closed, will immediately ...

Hyderabad: Granules India Limited has announced the signing of the acquisition agreement regarding Senn Chemicals AG, a Swiss-based CDMO specializing in peptides. Senn develops and manufactures, ...

Granules India Limited has acquired Senn Chemicals AG, a Swiss-based contract development and manufacturing organisation (CDMO) specialising in peptides, for Rs 192 crore. The closing of the ...

MUMBAI, Feb 22: Pharma major, Granules India on Saturday said that its board has approved to acquire 100% stake in Senn Chemicals AG, a Swizterland based company, for a total consideration of Rs 192.5 ...

Granules India Limited on Friday announced the signing of the acquisition agreement regarding Senn Chemicals AG, a Swiss-based CDMO specializing in peptides. The company said that this acquisition ...

Granules India has inked a pact to acquire Senn Chemicals AG, a Swiss-based Contract Development and Manufacturing Organisation (CDMO) specialising in peptides for ₹192 crore. “The ...